Open Access Peer-reviewed Research Article

Network pharmacology-based prediction for therapeutic mechanism of FuYueKang Lotion on acute eczema

Article Sidebar

network analysis
Download PDF
Submitted   Aug 30, 2023
Published   Nov 1, 2023
Issue    Vol 5 No 1 (2023)
DOI   10.25082/JPBR.2023.01.002

Views

1035

Downloads

399

Citations

PlumX Metrics

Main Article Content

Xiaowen Wen
Department of Dermatology, Shenzhen Hospital of Guangzhou univercity of Chinese Medicine(futian), Shenzhen 518000, China
Shaokang Cui
Equipment division, Zhongshan Hospital of Traditional Chinese Medicine, Guangzhou 528400, China
Minzhi Li
Department of Dermatology, Zhongshan Hospital of Traditional Chinese Medicine, Guangzhou 528400, China
Yongping Zheng
Department of Dermatology, Zhongshan Hospital of Traditional Chinese Medicine, Guangzhou 528400, China
Haoyou Xu corresponding author
Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China

Abstract

Objective: Fuyuekang Lotion (FYKL) is an improved traditional Chinese medicine (TCM) prescription widely used to treat acute eczema (AE). However, the mechanism of action remains unclear. This study aimed to explore the therapeutic mechanism of FYKL in AE.
Methods: We revealed the underlying mechanism by utilizing a network pharmacology approach, molecular docking studies, and in vitro verification. The active compounds in FYKL were identified, and their targets were predicted. These targets were subsequently mapped to a component-target interaction network, with their therapeutic mechanisms predicted through Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses. Molecular docking was used to verify protein-binding efficacy. Potential key targets of FYKL against AE were further confirmed via reverse transcription quantitative polymerase chain reaction (RT-qPCR).
Results: The study identified 59 potential active compounds of FYKL, with quercetin, luteolin, and gallic acid suggested as critical active ingredients. Our findings suggest that these ingredients could exert their effects mainly by modulating the inflammatory immune response and promoting epidermal repair. FYKL was found to be a multi-target, multi-component drug that could potentially regulate the inflammatory immune response in AE through numerous pathways.
Conclusions: The findings from this study provide a scientific basis for further research into the therapeutic effects and mechanisms of FYKL in treating AE, underscoring the potential of TCM in modern therapeutics.

Keywords
Fuyuekang Lotion, acute eczema, network pharmacology, molecular docking, Traditional Chinese medicine

Article Details

Supporting Agencies
This work was supported by the Guangdong Provincial PhD Station funding, Zhongshan Social Welfare and Basic Research Project (No. 2021B1063).
How to Cite
Wen, X., Cui, S., Li, M., Zheng, Y., & Xu, H. (2023). Network pharmacology-based prediction for therapeutic mechanism of FuYueKang Lotion on acute eczema. Journal of Pharmaceutical and Biopharmaceutical Research, 5(1), 366-381. https://doi.org/10.25082/JPBR.2023.01.002
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

References

  1. de Lusignan S, Alexander H, Broderick C, et al. The epidemiology of eczema in children and adults in England: A population-based study using primary care data. Clinical and Experimental Allergy. 2020, 51(3): 471-482. https://doi.org/10.1111/cea.13784
  2. Ellis CN, Drake LA, Prendergast MM, et al. Cost of atopic dermatitis and eczema in the United States. Journal of the American Academy of Dermatology. 2002, 46(3): 361-370. https://doi.org/10.1067/mjd.2002.120528
  3. Hay RJ, Johns NE, Williams HC, et al. The Global Burden of Skin Disease in 2010: An Analysis of the Prevalence and Impact of Skin Conditions. Journal of Investigative Dermatology. 2014, 134(6): 1527-1534. https://doi.org/10.1038/jid.2013.446
  4. Nowicki R, Trzeciak M, Wilkowska A, et al. Special paper Atopic dermatitis: current treatment guidelines. Statement of the experts of the Dermatological Section, Polish Society of Allergology, and the Allergology Section, Polish Society of Dermatology. Advances in Dermatology and Allergology. 2015, 4: 239-249. https://doi.org/10.5114/pdia.2015.53319
  5. Gu SX, Zhang AL, Coyle ME, et al. Chinese herbal medicine granules (PTQX) for children with moderate to severe atopic eczema: study protocol for a randomised controlled trial. Trials. 2015, 16(1). https://doi.org/10.1186/s13063-015-0806-y
  6. Wang Z, Wang ZZ, Geliebter J, Tiwari R, Li XM. Traditional Chinese medicine for food allergy and eczema. Annals of Allergy, Asthma and Immunology. 2021, 126(6): 639-654. https://doi.org/10.1016/j.anai.2020.12.002
  7. Zhang L, Lin S, Zheng Y, Wang H. Matrine Regulates Th1/Th2 Balance to Treat Eczema by Upregulating Interferon-$gamma$. Journal of Nanoscience and Nanotechnology. 2020, 20(6): 3378-3386. https://doi.org/10.1166/jnn.2020.17417
  8. Hwang SJ, Song YS, Lee HJ. Phaseolin Attenuates Lipopolysaccharide-Induced Inflammation in RAW 264.7 Cells and Zebrafish. Biomedicines. 2021, 9(4): 420. https://doi.org/10.3390/biomedicines9040420
  9. Zhou W, Hu M, Hu J, Du Z, Su Q, Xiang Z. Luteolin Suppresses Microglia Neuroinflammatory Responses and Relieves Inflammation-Induced Cognitive Impairments. Neurotoxicity Research. 2021, 39(6): 1800-1811. https://doi.org/10.1007/s12640-021-00426-x
  10. Zhang L, Lin S, Zheng Y. Observation on the efficacy of Fuyuekang lotion in the treatment of acute (subacute) eczema. Guangming Traditional Chinese Medicine. 2015, 30(5): 987-988.
  11. Chen S, Jiang H, Cao Y, et al. Drug target identification using network analysis: Taking active components in Sini decoction as an example. Scientific Reports. 2016, 6(1). https://doi.org/10.1038/srep24245
  12. Zhang R, Zhu X, Bai H, Ning K. Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment. Frontiers in Pharmacology. 2019, 10. https://doi.org/10.3389/fphar.2019.00123
  13. Ru J, Li P, Wang J, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. Journal of Cheminformatics. 2014, 6(1). https://doi.org/10.1186/1758-2946-6-13
  14. Xue R, Fang Z, Zhang M, Yi Z, Wen C, Shi T. TCMID: traditional Chinese medicine integrative database for herb molecular mechanism analysis. Nucleic Acids Research. 2012, 41(D1): D1089-D1095. https://doi.org/10.1093/nar/gks1100
  15. Kim S, Chen J, Cheng T, et al. PubChem 2019 update: improved access to chemical data. Nucleic Acids Research. 2018, 47(D1): D1102-D1109. https://doi.org/10.1093/nar/gky1033
  16. Ferreira LLG, Andricopulo AD. ADMET modeling approaches in drug discovery. Drug Discovery Today. 2019, 24(5): 1157-1165. https://doi.org/10.1016/j.drudis.2019.03.015
  17. Law V, Knox C, Djoumbou Y, et al. DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Research. 2013, 42(D1): D1091-D1097. https://doi.org/10.1093/nar/gkt1068
  18. Chen X. TTD: Therapeutic Target Database. Nucleic Acids Research. 2002, 30(1): 412-415. https://doi.org/10.1093/nar/30.1.412
  19. Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Research. 2019, 47(W1): W357-W364. https://doi.org/10.1093/nar/gkz382
  20. Fu X, Mervin LH, Li X, et al. Toward Understanding the Cold, Hot, and Neutral Nature of Chinese Medicines Using in Silico Mode-of-Action Analysis. Journal of Chemical Information and Modeling. 2017, 57(3): 468-483. https://doi.org/10.1021/acs.jcim.6b00725
  21. Safran M, Dalah I, Alexander J, et al. GeneCards Version 3: the human gene integrator. Database. 2010, 2010(0): baq020-baq020. https://doi.org/10.1093/database/baq020
  22. Piñero J, Bravo À, Queralt-Rosinach N, et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Research. 2016, 45(D1): D833-D839. https://doi.org/10.1093/nar/gkw943
  23. Hamosh A. Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Research. 2002, 30(1): 52-55. https://doi.org/10.1093/nar/30.1.52
  24. Davis AP, Grondin CJ, Johnson RJ, et al. Comparative Toxicogenomics Database (CTD): update 2021. Nucleic Acids Research. 2020, 49(D1): D1138-D1143. https://doi.org/10.1093/nar/gkaa891
  25. Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Research. 2018, 47(D1): D607-D613. https://doi.org/10.1093/nar/gky1131
  26. Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Systems Biology. 2014, 8(S4). https://doi.org/10.1186/1752-0509-8-s4-s11
  27. Shannon P, Markiel A, Ozier O, et al. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Research. 2003, 13(11): 2498-2504. https://doi.org/10.1101/gr.1239303
  28. Bader GD, Hogue CW. BMC Bioinformatics. 2003, 4(1): 2. https://doi.org/10.1186/1471-2105-4-2
  29. Huang DW, Sherman BT, Tan Q, et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Research. 2007, 35(S2): W169-W175. https://doi.org/10.1093/nar/gkm415
  30. Pawar SS, Rohane SH. Review on Discovery Studio: An important Tool for Molecular Docking. Asian Journal Of Research in Chemistry. 2021, 14(1): 1-3. https://doi.org/10.5958/0974-4150.2021.00014.6
  31. Jin X, Awale M, Zasso M, Kostro D, Patiny L, Reymond JL. PDB-Explorer: a web-based interactive map of the protein data bank in shape space. BMC Bioinformatics. 2015, 16(1). https://doi.org/10.1186/s12859-015-0776-9
  32. Gagnon JK, Law SM, Brooks CL. Flexible CDOCKER: Development and application of a pseudo‐explicit structure‐based docking method within CHARMM. Journal of Computational Chemistry. 2015, 37(8): 753-762. https://doi.org/10.1002/jcc.24259
  33. Zheng J, Yao L, Zhou Y, et al. A novel function of NLRP3 independent of inflammasome as a key transcription factor of IL-33 in epithelial cells of atopic dermatitis. Cell Death and Disease. 2021, 12(10). https://doi.org/10.1038/s41419-021-04159-9
  34. Dehne N, Brüne B. HIF-1 in the inflammatory microenvironment. Experimental Cell Research. 2009, 315(11): 1791-1797. https://doi.org/10.1016/j.yexcr.2009.03.019
  35. Wu L, Zhang Q, Liang W, Ma Y, Niu L, Zhang L. Phytochemical Analysis Using UPLC-MSn Combined with Network Pharmacology Approaches to Explore the Biomarkers for the Quality Control of the Anticancer Tannin Fraction of Phyllanthus emblica L. Habitat in Nepal. Hu W, ed. Evidence-Based Complementary and Alternative Medicine. 2021, 2021: 1-19. https://doi.org/10.1155/2021/6623791
  36. Yang B, Kortesniemi M, Liu P, Karonen M, Salminen JP. Analysis of Hydrolyzable Tannins and Other Phenolic Compounds in Emblic Leafflower (Phyllanthus emblica L.) Fruits by High Performance Liquid Chromatography–Electrospray Ionization Mass Spectrometry. Journal of Agricultural and Food Chemistry. 2012, 60(35): 8672-8683. https://doi.org/10.1021/jf302925v
  37. Jafarinia M, Sadat Hosseini M, kasiri N, et al. Quercetin with the potential effect on allergic diseases. Allergy, Asthma and Clinical Immunology. 2020, 16(1). https://doi.org/10.1186/s13223-020-00434-0
  38. Lee HN, Shin SA, Choo GS, et al. Anti‑inflammatory effect of quercetin and galangin in LPS-stimulated RAW264.7 macrophages and DNCB‑induced atopic dermatitis animal models. International Journal of Molecular Medicine. Published online November 29, 2017. https://doi.org/10.3892/ijmm.2017.3296
  39. Mehrbani M, Choopani R, Fekri A, Mehrabani M, Mosaddegh M, Mehrabani M. The efficacy of whey associated with dodder seed extract on moderate-to-severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled clinical trial. Journal of Ethnopharmacology. 2015, 172: 325-332. https://doi.org/10.1016/j.jep.2015.07.003
  40. Gendrisch F, Esser PR, Schempp CM, Wölfle U. Luteolin as a modulator of skin aging and inflammation. BioFactors. 2020, 47(2): 170-180. https://doi.org/10.1002/biof.1699
  41. Kempuraj D, Thangavel R, Kempuraj DD, et al. Neuroprotective effects of flavone luteolin in neuroinflammation and neurotrauma. BioFactors. 2020, 47(2): 190-197. https://doi.org/10.1002/biof.1687
  42. Bai J, Zhang Y, Tang C, et al. Gallic acid: Pharmacological activities and molecular mechanisms involved in inflammation-related diseases. Biomedicine and Pharmacotherapy. 2021, 133: 110985. https://doi.org/10.1016/j.biopha.2020.110985
  43. Chan HHL, Ng T. Traditional Chinese Medicine (TCM) and Allergic Diseases. Current Allergy and Asthma Reports. 2020, 20(11). https://doi.org/10.1007/s11882-020-00959-9
  44. Diao Q, Liu Y. Diagnosis and Treatment of Hang Eczema: a Chinese Expert Consensus Statement (2020). Chinese Journal of Dermatovenereology of Integrated Traditional and Western Medicine, 2021, 20(5): 517-521.
  45. Shi DH, Dai YP, Su BZ, et al. Study on internal and external quality control methods of Platycladi Cacumen Carbonisata based on QAMS and color recognition. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica, 2020, 45(24): 5996-6002.
  46. Darby IA, Hewitson TD. Hypoxia in tissue repair and fibrosis. Cell and Tissue Research. 2016, 365(3): 553-562. https://doi.org/10.1007/s00441-016-2461-3
  47. Manresa MC, Smith L, Casals-Diaz L, et al. Pharmacologic inhibition of hypoxia‐inducible factor (HIF)-hydroxylases ameliorates allergic contact dermatitis. Allergy. 2018, 74(4): 753-766. https://doi.org/10.1111/all.13655
  48. Sun L, Liu W, Zhang L juan. The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis. Journal of Immunology Research. 2019, 2019: 1-13. https://doi.org/10.1155/2019/1824624